Generic Hospice

When hospice reverts to the lowest common denominator and leaders obsess about metrics, it's time to speak. Self-inflated leaders assume clinicians give until their backs break, given no raises for years. A clinical ladder is a rainbow’s pot of gold. Others have a sorrier job and must be motivated by money. Abysmal leaders dangle extrinsic rewards for admission, hiring and EDBITA targets. “Sign on” bonuses entice people into a poor work environment. Employees’ voice equals their raise, zero.

Tuesday, May 20, 2014

Kindred-Gentiva Selling to the Middle 60%

Two facts surfaced in Kindred's hostile pursuit of Gentiva. One, Gentiva insiders control roughly 20% of the company's outstanding shares. And two, roughly 20% of stockholders hold positions in both Gentiva and Kindred. That leaves the middle 60% to decide Gentiva's future in any proxy battle. That's a lot of sales calls.

Generic Hospice

Tuesday, May 20, 2014

Kindred-Gentiva Selling to the Middle 60%

No comments:

Post a Comment